Navigation Links
St. John Hospital 1st in Region to Offer Innovative Chemotherapy Delivery System
Date:11/4/2011

DETROIT, Nov. 4, 2011,  /PRNewswire-USNewswire/ -- A unique treatment involving the use of hot chemotherapy is being offered at St. John Hospital and Medical Center. SJH&MC is the first hospital in Southeast Michigan and one of only approximately 20 centers nationwide to offer the treatment.

Know as Hyperthermic Intraperitoneal Chemotherapy, or HIPEC, the procedure has applications for a number of advanced cancers that have spread to the lining of the abdominal cavity, including colorectal, gastric, ovarian, appendiceal, and mesothelioma. For these patients, chemotherapy through a vein can only give them an additional few months to live.

The treatment involves surgically removing cancerous tumors from the abdominal cavity, then bathing the cavity with hot chemotherapy. The surgeon continuously circulates a heated, sterile chemotherapy solution throughout the abdominal cavity for up to two hours, killing remaining cancer cells without damaging normal cells in the body. The solution is then removed and the incision is closed.

Delivering the heated chemotherapy throughout the abdominal cavity distributes the drug thoroughly and allows it to directly penetrate the areas of cancer and reach areas where cancer cells aren't easily visible. Because the chemotherapy is delivered directly to the tumor, many of the side effects associated with intravenous administration of these powerful drugs can be avoided.

"This procedure has been proven to extend the lives of patient's and improve their quality of life," says Richard Berri, M.D., director of surgical oncology at St. John Hospital and one of only surgeons in the world trained to perform the operation. For many patients with advanced cancers that have spread to the abdominal cavity this is their only viable treatment option. Unlike other cancer treatments that only treat the symptoms of abdominal cancers; HIPEC can actually stop the growth of abdominal cancers."

St. John Hospital and Medical Center's Surgical Oncology Program, led by Dr. Berri, provides the most comprehensive and current surgical evaluation and treatment to patients with malignancies that can be treated surgically, including pancreas, liver, colorectal and stomach cancer. SJH&MC also offers the only Peritoneal Malignancies Program in Michigan to offer HIPEC.


'/>"/>
SOURCE St. John Providence Health System
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. MedImmunes Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study
2. Gilbert Hospital Continues Cutting Edge Treatments
3. Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission
4. New Data Show Doripenem as Effective as Commonly Used Therapies in Treating Hospital-Acquired Pneumonias
5. AspenBio Pharma Reports Strong Results with Appendicitis Triage Blood Test from Large Multiple Hospital Study
6. INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients
7. Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals
8. Hospital to Hold MRSA Briefing for Media and Community Leaders
9. Arizona Heart Hospital Reaches Settlement Regarding Clinical Research Matter
10. Providence Hospital Study Finds Communication System Leads to Faster Heart Attack Treatment
11. Allegheny General Hospital Performs First Liver Transplant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 2016 The Academy of Managed Care Pharmacy ... that would allow biopharmaceutical companies to more easily share ... formulary and coverage decisions, a move that addresses the ... The recommendations address restrictions in the sharing ... drug label, a prohibition that hinders decision makers from ...
(Date:6/24/2016)... , June 24, 2016 ... Market by Type (Standard Pen Needles, Safety Pen Needles), ... (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) ... MarketsandMarkets, This report studies the market for the forecast ... to reach USD 2.81 Billion by 2021 from USD ...
(Date:6/23/2016)... 2016  MedSource announced today that it has ... solution of choice.  This latest decision demonstrates MedSource,s ... their clients by offering a state-of-the-art electronic data ... nowEDC as the EDC platform of choice in ... "nowEDC has long been a preferred EDC platform ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... ... Scientific Sessions in Dallas that it will receive two significant new grants to ... came as PHA marked its 25th anniversary by recognizing patients, medical professionals and ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
(Date:6/24/2016)... ... 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ... raise to $12 an hour by 2020 and then adjusting it yearly to increase at ... the minimum wage, assure the wage floor does not erode again, and make future increases ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented its first-ever ... Medicine conference in Ponte Vedra Beach, FL. The awards honor the outstanding work ... Practice and Pediatric Emergency Medicine Practice. , “With this award, we recognize ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... The Grove Investment Group (TGIG), has initiated cultivation and processing operations at its ... Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete system ...
Breaking Medicine News(10 mins):